-+ 0.00%
-+ 0.00%
-+ 0.00%

Hyliion (HYLN) Stock Eyes Navy Backing While Losses Keep Building

Simply Wall St·08/12/2026 22:38:16
Listen to the news

Hyliion Holdings came into this report on a quiet upswing, with the stock up modestly over the past three months, and then barely moved on the day, slipping only 0.8% to about $3.89. That muted reaction masks a much louder headline. The quarter was defined by a large U.S. Navy award and a jump in R&D services revenue that pushed Q2 revenue to $4.9m and prompted management to lift full year 2026 revenue guidance to about $15m.

For a company still reporting sizeable quarterly losses, the story this time is the tension between that growing contract book and the cash it continues to consume.

Is Hyliion Holdings trading ahead of its fundamentals or just starting to reflect future revenue potential? Compare the current $3.89 share price against our detailed valuation analysis for Hyliion Holdings

Q2 2026 Earnings Summary

  • Revenue (Q2 2026 vs. Q2 2025): US$4.9m vs. US$1.5m (strong year on year increase driven by R&D services)
  • Net Loss (Q2 2026 vs. Q2 2025): US$13.9m loss vs. US$13.4m loss (slightly wider quarterly loss)
  • Basic EPS (Q1 2026 vs. Q2 2025): US$0.07 loss per share vs. US$0.08 loss per share (modest improvement on a per share basis)
  • Operating Expenses (Q2 2026): US$15.7m total, with R&D at US$9.5m and SG&A at US$6.4m (R&D down 23% year on year in H1 2026)

If you prefer clear visual charts to long lists of earnings figures and contract details, explore Hyliion Holdings with an at-a-glance view of its balance sheet strength in the company report for Hyliion Holdings.

NYSEAM:HYLN Trailing 12-Month Earnings & Revenue History as at Aug 2026
NYSEAM:HYLN Trailing 12-Month Earnings & Revenue History as at Aug 2026

Hyliion’s Bull Story Hangs On Real Commercial Proof

The bullish pitch on Hyliion Holdings is that KARNO is moving from a lab project to a real power product backed by early customers. This quarter gives some concrete progress, but mostly on the prerequisites rather than the end goal of product revenue. Revenue of US$4.9m was entirely from R&D services, so the hoped-for shift toward product sales has not started yet.

Where the thesis does get support is on milestones that underpin future orders. The US$41.7m U.S. Navy award and expectations for roughly US$50m of new military contracts in 2026 show that defense customers are committing engineering dollars to KARNO. Multi-module operation has already been shown and management now targets about 10 KARNO cores this year with the first customer site deployment next quarter. Those steps validate technical and defense demand claims, but conversion of the 750 core LOI pipeline into binding orders is still unproven.

Compare how Hyliion Holdings talks about its growing contract pipeline with how institutions are pricing that story. See the consensus price target analysis for Hyliion Holdings to check whether Wall Street expects this progress to translate into a different share price path.

Bear Case On Hyliion’s Commercialization Timelines Holds Up

The bearish view is that Hyliion Holdings is too reliant on a narrow R&D contract base and is slow to turn KARNO into a repeatable product business. Q2 results largely back that up. The entire US$4.9m of revenue still comes from R&D services and not from product sales. The company raised 2026 revenue guidance to about US$15m, yet management now aims to push 200 kW unit commercialization into 2027 and targets multi megawatt data center systems initially ready in 2028. That timing shift means operating leverage is still out of reach, while quarterly losses remain sizeable at US$13.9m. Bears also worry that LOIs are not firm orders. The short seller attack on the US$133m VFG Holdings LOI and ongoing legal probes keep that concern alive, and this quarter did not deliver any new data center purchase orders to contradict it.

After a quarter in which Hyliion Holdings remains loss making, reliant on R&D revenue and facing share price swings, it is worth asking whether these pressures are isolated or part of a broader pattern of structural fragilities. Review our independent risk analysis for Hyliion Holdings which shows 2 important warning signs

Stay Ahead Of Your Next Move

If Hyliion Holdings has your attention after its mix of R&D driven revenue and ongoing losses, register for free with Simply Wall St and add it to a Watchlist to track price against fair value and watch how new contracts and commercialization steps feed into the story. Once you decide to build a position, use the Portfolio Command Center to cut through market noise and focus on the most important developments hitting your holdings. Over the long run, lean on the Community to see how other investors are interpreting fresh contracts, guidance changes and risk flags. That way you can surface hidden catalysts and potential risks early and stay a step ahead of the market.

Seeking Alternatives Beyond Hyliion Holdings

Fresh stock stories are forming right now. Some are building quiet breakout momentum and others are still under the radar for now. Do not get caught watching. Act now.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.